Investigators conducted a scoping review of randomized controlled trials that evaluated the impact of cognitive behavioral therapy on symptoms of depression and anxiety among patients with type 2 diabetes.
Investigators with Brigham and Women’s Hospital sourced data for this study from the Medicaid Analytic eXtract (MAX) and IBM Health MarketScan Research Database.
For this analysis, data from the Irish arm of the COVID-19 Psychological Research Consortium (C19PRC) study were investigated.
This study sourced data from the Ethanol, Neurodevelopment, Infant and Child Health (ENRICH) cohort which recruited women with a singleton pregnancy at the University of New Mexico affiliated prenatal care clinics.
Investigators at the First Affiliated Hospital of Harbin Medical University in China searched publication databases through March 2021 for studies of noninvasive brain stimulation treatments for OCD.
For this study, patients with new-onset schizophrenia, schizophreniform disorder, or brief psychotic episode were recruited from the University Hospital of Ioannina in Greece between 2018 and 2020.
Investigators from The Hong Kong Polytechnic University searched publication databases through January 2021 for studies of neuroimaging analyses among patients with schizophrenia and healthy controls.
Investigators from Oklahoma State University Center for Health Sciences evaluated randomized controlled trials of MDD published between 2016 and 2020 for the quality of their PRO reporting.
An investigator at the University of Liverpool searched publication databases through 2020 for studies of dermatoglyphics, digit ratio, and palmar crease in conjunction with mental illness.
Investigators assessed whether depressive symptoms, eating disorders, and health-related quality of life were related to a diagnosis of type 2 diabetes in youth and young adults.
